Emerging Molecular Imaging Techniques in Gynecologic Oncology

PET Clinics
Gigin LinTzu-Chen Yen

Abstract

Molecular imaging (mainly PET and MR imaging) has played important roles in gynecologic oncology. Emerging MR-based technologies, including DWI, CEST, DCE-MR imaging, MRS, and DNP, as well as FDG-PET and many novel PET radiotracers, will continuously improve practices. In combination with radiomics analysis, a new era of decision making in personalized medicine and precisely guided radiation treatment planning or real-time surgical interventions is being entered into, which will directly impact on patient survival. Prospective trials with well-defined endpoints are encouraged to evaluate the multiple facets of these emerging imaging tools in the management of gynecologic malignancies.

Citations

Jun 17, 2019·European Journal of Nuclear Medicine and Molecular Imaging·Andreas HolzingerIgor Jurisica
Nov 18, 2020·Journal of Magnetic Resonance Imaging : JMRI·Kristine E FasmerIngfrid H S Haldorsen
Oct 22, 2019·Seminars in Nuclear Medicine·Jukka KemppainenMarko Seppänen
Feb 11, 2021·International Journal of Molecular Sciences·Hashem O AlsaabYusuf S Althobaiti

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Imaging

Imaging techniques, including CT and MR, have become essential to tumor detection, diagnosis, and monitoring. Here is the latest research on cancer imaging.

Related Papers

PET Clinics
Drew A Torigian, Domenico Rubello
Clinical Positron Imaging : Official Journal of the Institute for Clinical P.E.T
L Boucher, F Bénard
© 2022 Meta ULC. All rights reserved